S9 Ep48: Donington and Stiles Describe the Surgical Implications of Lung Cancer Treatment Evolutions

from OncLive® On Air · host OncLive® On Air

Drs Donington and Stiles discuss how the findings from the ADAURA trial with adjuvant osimertinib have changed thoracic surgery expectations, the potential surgical implications of the ALINA trial with adjuvant alectinib, and the importance of early-stage molecular testing in lung cancer.

Episode metadata supplied by the publisher feed · Published Dec 11, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

S9 Ep48: Donington and Stiles Describe the Surgical Implications of Lung Cancer Treatment Evolutions

0:00 11:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 11 minutes long.

When was this OncLive® On Air episode published?

This episode was published on December 11, 2023.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!